Data / Form D filings / Enlaza Therapeutics, Inc.
Enlaza Therapeutics, Inc.: Form D filings
Enlaza Therapeutics, Inc., a pharmaceuticals company in La Jolla, CA, filed 8 Form D notices with the SEC between 2021 and 2025. The latest, on September 11, 2025, reports $15 million sold of a $15 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11099 NORTH TORREY PINES ROAD, STE. 280, La Jolla, CA, 92037
- Phone
- (858) 348-2180
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1852950
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | New notice | $15,000,000 | $15,000,000 | 1 | Aug 29, 2025 | sec.gov | |
| Aug 9, 2024 | New notice | $110,000,000 | $84,000,000 | $26,000,000 | 16 | Apr 5, 2024 | sec.gov |
| Nov 22, 2022 | Amendment | $61,330,607 | $35,299,237 | $26,031,370 | 10 | Mar 12, 2021 | sec.gov |
| Oct 13, 2022 | New notice | $311,977 | $0 | $311,977 | 1 | Oct 4, 2022 | sec.gov |
| Oct 13, 2022 | New notice | Indefinite | $0 | 1 | Sep 30, 2022 | sec.gov | |
| Aug 13, 2021 | New notice | Indefinite | $0 | 1 | Jul 30, 2021 | sec.gov | |
| Jun 28, 2021 | New notice | Indefinite | $0 | 1 | Jun 10, 2021 | sec.gov | |
| Mar 25, 2021 | New notice | $21,273,287 | $4,018,630 | $17,254,657 | 7 | Mar 12, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Marcos Milla | Director | |
| Stephen Squinto | Director | |
| Tighe Reardon | Executive Officer | |
| Jay Lichter | Director | |
| Shelley Chu | Director | |
| Sergio Duron | Executive Officer, Director | |
| James Topper | Director | |
| Sanford Madigan | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Sep 8, 2025 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Enlaza Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.